Diabetes Mellitus Clinical Trial
Official title:
Corneal Changes in Diabetics After Phacoemulsification
This study aims to assess the corneal damage after phacoemulsification and to assess the factors causing it in diabetics in comparison with non-diabetics.
Title:
Corneal changes in diabetics after phacoemulsification
Introduction:
Cataract is one of the common cause of reversible blindness. In diabetics, Age-related
cataract occurs earlier and nuclear cataract is more common and tends to progress rapidly.
True diabetic cataract is a rare condition usually occurring in young adults due to the
osmotic over-hydration of the lens. Initially a large number of fluid vacuoles appear
underneath the anterior and posterior capsules, which is soon followed by the appearance of
bilateral snowflake-like white opacities in the cortex.
Diabetic hyperglycemia also inhibits the function of Na+ k+ ATPase activity thereby causing
dysfunction of the corneal endothelial cell layer. The endothelial cell morphology is also
abnormal in diabetics. Polymegathism and Pleomorphism are noted. The cornea is also found to
be thicker in diabetics owing to the slower recovery of corneal edema.
Phacoemulsification with intraocular lens implantation is one of the most common surgical
procedures performed for cataract surgery with a smaller incision, which decreases the
tissue injury, reduces post-operative pain and inflammation, and provides a rapid refractive
stabilization. Surgeries that are done for cataract result in decrease in the endothelial
count of which phacoemulsification has lesser degree of endothelial damage compared to those
of other surgeries. Parameters like nucleus density(1), axial length(2) and the ultrasound
power(3) also influence the endothelial cell count after phacoemulsification.
Aims and objectives:
1. To assess the central corneal thickness and endothelium after phacoemulsification in
diabetics in comparison with non-diabetics.
2. To assess the factors associated with Corneal endothelial cell damage after
phacoemulsification in diabetics in comparison with non-diabetics.
Review of literature:
Shultz et al(4) in the study on morphologic changes in corneal endothelial cells in
diabetics for a duration of more than 21 years, found that diabetic corneal endothelial cell
changes are caused continuously even after ocular operations, because the diabetic cornea is
unstable and vulnerable. They found annual rates of reduction in corneal endothelial cells
were 2.5% per year in operated eyes having extracapsular cataract extraction and 0.3% to
0.5% in normal individuals, thus showing a higher reduction rate in the surgically treated
eyes by 10 year analysis.
Furuse and coauthors(5) compared the morphologic changes in corneal endothelial cells after
performing planned Extra capsular cataract extraction on 96 normal aged cataract patients
and diabetic patients. They observed that there was no significant difference between the 2
groups in terms of the density of corneal endothelial cells, the co-efficient of variation
in cell size, and the cell hexagonality until 12 months postoperatively.
Goebbels and spitznas(6) performed flurophotometry of the corneal endothelium before and 4
days, 3 weeks and 6 weeks after phacoemulsification and intraocular lens implantation and
endothelial permeability was evaluated in the presence or absence of diabetes mellitus.
Endothelial permeability did not differ between the diabetic and non diabetic groups before
operation, markedly increased in both groups 4 days after operation and recovered 3 weeks
after operation in the non diabetic group but 6 weeks after operation in the diabetic group.
This result was consistent with delayed recovery of endothelial function in the cornea of
diabetic patients after cataract surgery.
Lee et al(7) studied the effect of the severity of retinopathy on endothelial loss post
phacoemulsification and found an increased loss of endothelial cells and increased
coefficient of variation in patients with high risk proliferative diabetic retinopathy when
compared with patients with non proliferative diabetic retinopathy or patients without
diabetes.
Su et al(8) designed a population based cross sectional study including 3239 eyes and
examined the relationship of diabetics and CCT. They found that diabetes is associated with
greater CCT, independent of age, sex and IOP levels.
Inoue et al(9) investigated corneal endothelial structure and corneal thickness in 99 eyes
with type 2 diabetes and 97 control eyes without diabetes. They found a decrease in cell
density and an increase in coefficient of variation and concluded that the corneal
endothelial cell structure was damaged.
Materials and methods:
Whether the study involves humans : Humans only or animals or both
Type of study : Case control study Number of groups : 2 groups. Group 1 -
phacoemulsification in diabetics Group 2 - phacoemulsification in non-diabetics.
Sample size : 80 patients in each group. The sample size is estimated with an expected
difference of 19 in corneal thickness at 5% level of significance and 80% power. The minimum
sample size estimated was 70 in each group. The sample size is further modified with an
expected drop out of 10%.
The protocol was approved by the Institute Ethical Committee. The study was done on patients
attending ophthalmology outpatient services for visual ailments.Essential data such as name,
age, sex and hospital number of patients enrolled were noted. The purpose and details of the
study were explained to each subject and after obtaining informed consent, patients were
recruited into the study.
Preoperatively, detailed ocular examination including visual acuity (using Snellen's chart
or equivalent E optotypes), refraction, slit lamp examination, corneal endothelial count and
morphology assessment (ECD, CV, hexagonality) using Konan noncon robo specular microscope
(Model - NSP 9900) and corneal thickness using ultrasonic pachymeter were done for all
patients planned for phacoemulsification surgery. Specular microscopy and pachymetry were
measured by the same observer for all subjects. CCT was measured after topical anesthesia
using one drop of proparacaine eye drops (0.5% w/v) and an average of three readings was
noted.
Intraoperative mydriasis, phacoemulsification time and power were noted. Postoperatively,
visual acuity, ocular inflammation scores, corneal thickness, CD, CV and hexagonality were
measured on the first week, six weeks and three months. Ocular inflammation score was
calculated based on the SUN (Standardization of uveitis nomenclature) working group grading
scheme for anterior chamber cells.
Method of analysis:
Test for differences between groups in terms of demographic and clinical characteristics was
done using the Chi-Square test for categorical variables. Independent student's t test or
Mann Whitney's U test was used for comparing continuous variables. To identify the
independent factors associated with the outcome, multiple logistic regression analysis was
used. Preoperative versus postoperative modifications within the groups were verified using
two-way repeated measures ANOVA. All statistical tests were carried out at 5% level of
significance and p value < 0.05 was considered statistically significant. Data analysis was
performed using SPSS (version 20.0, SPSS Inc.).
Hypothesis:
There is an Increase in central corneal thickness and decrease in corneal endothelial count
after phacoemulsification surgery in diabetics in comparison to non-diabetics.
;
Observational Model: Case Control, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
| Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
| Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
| Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
| Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
| Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
| Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
| Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
| Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
| Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
| Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
| Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
| Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
| Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
| Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
| Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |